The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy
Abstract
Background & aims Minimal hepatic encephalopathy (MHE) is the mildest form in the spectrum of hepatic encephalopathy. This cross-sectional study was carried out to elucidate the role of bacterial overgrowth of the small intestine and delayed intestinal transit among patients with MHE. Methods Two-hundred-thirty patients with cirrhosis were screened; 102 patients (44.4%) who met the eligibility criteria were included in the study. MHE was diagnosed when the psychometric hepatic encephalopathy score was ≤-5. All patients underwent a glucose breath test for small intestinal bacterial overgrowth (SIBO) and lactulose breath test for oro-cecal transit time (OCTT). Results Fifty-seven (55.9%) patients with cirrhosis had MHE. Among these patients with MHE, 22 (38.6%) had SIBO, while 4 (8.9%) without MHE had SIBO (p = 0.001). The prevalence of SIBO was higher in patients with CTP classes B and C (69.2%) compared to those in CTP class A (30.8%); p = 0.054. OCTT was significantly prolonged in patients who had SIBO than in those who did not have SIBO (p Conclusions Our study conclusively demonstrates high prevalence of SIBO in patients with cirrhosis with MHE. This study gives the rationale of treatment directed against SIBO and gut dysmotility, which may include non-absorbable antibiotics such as rifaximin, probiotics, and prokinetics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the potential contributors of the microbiota to complications of liver cirrhosis is the presence of SIBO [73] , and a dysfunctional mucosal barrier which can contribute to bacterial (or endotoxin) translocation to the portal circulation [74] .”
From Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis (2014) · cites this paper as [73]
Citations
Cites
Ferenci, P., Lockwood, A. H., Mullen, K. D., Tarter, R. E., Weißenborn, K., & Blei, A. T. (2002) · Hepatology · doi:10.1053/jhep.2002.31250 · Cited by 2,035
Neuropsychological characterization of hepatic encephalopathy
Weißenborn, K., Ennen, J. C., Schomerus, H., Rückert, N., & Hecker, H. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00026-5 · Cited by 796
Liu, Q., Duan, Z. P., Ha, D. K., Bengmark, S., Kurtovic, J., & Riordan, S. M. (2004) · Hepatology · doi:10.1002/hep.20194 · Cited by 636
Prasad, S., Dhiman, R. K., Duseja, A. K., Chawla, Y. K., Sharma, A., & Agarwal, R. (2007) · Hepatology · doi:10.1002/hep.21533 · Cited by 602
Self-citationSubclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy
Romero‐Gómez, M., Boza, F., Garci'a-Valdecasas, M. S., Garci'a, E., & Aguilar‐Reina, J. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04130.x · Cited by 411
Incomplete Absorption of the Carbohydrate in All-Purpose Wheat Flour
Anderson, I. H., Levine, A. S., & Levitt, M. D. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104093041507 · Cited by 378
Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic Encephalopathy
Lockwood, A. H., Yap, E. W. H., & Wong, W. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.67 · Cited by 335
Small Intestinal Bacterial Overgrowth: Roles of Antibiotics, Prebiotics, and Probiotics
Quigley, E. M. M., & Quera, R. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.046 · Cited by 330
Value of the critical flicker frequency in patients with minimal hepatic encephalopathy†
Romero‐Gómez, M., Córdoba, J., Jover, R., del Olmo, J. A., Ramirez, M. C., Rey, R., de‐Madaria, E., Montoliu, C., Nuñez, D., Flavià, M., et al. (2007) · Hepatology · doi:10.1002/hep.21586 · Cited by 323
Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis
Das, A., Dhiman, R. K., Saraswat, V. A., Verma, M., & Naik, S. R. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02487.x · Cited by 298
Self-citation
Cited by
Sorted by citations
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
The Human Microbiota in Health and Disease
Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017) · Engineering · doi:10.1016/j.eng.2017.01.008 · Cited by 916
Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis
Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533
Gut microbiome and liver diseases
Tilg, H., Cani, P. D., & Mayer, E. A. (2016) · Gut · doi:10.1136/gutjnl-2016-312729 · Cited by 525
for the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
Sharma, B. C., Sharma, P., Lunia, M. K., Srivastava, S., Goyal, R., & Sarin, S. K. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.219 · Cited by 343
Cheung, K.-H., Lee, S. S., & Raman, M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.016 · Cited by 340
Dhiman, R. K., Rana, B., Agrawal, S., Garg, A., Chopra, M., Thumburu, K. K., Khattri, A., Malhotra, S., Duseja, A., & Chawla, Y. K. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.031 · Cited by 339
Self-citationThe intestinal microbiota and chronic disorders of the gut
Dupont, A. W., & DuPont, H. L. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.133 · Cited by 310
Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk
Hartmann, P., Seebauer, C. T., & Schnabl, B. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12704 · Cited by 285
The gut microbiota: A treasure for human health
Li, D., Wang, P., Wang, P., Hu, X., & Chen, F. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.08.003 · Cited by 271
Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258
Bellot, P., Francés, R., & Such, J. M. (2012) · Liver International · doi:10.1111/liv.12021 · Cited by 255
Romero‐Gómez, M., Montagnese, S., & Jalan, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.09.005 · Cited by 254
Microbiota and the gut-liver axis: Bacterial translocation, inflammation and infection in cirrhosis
Giannelli, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i45.16795 · Cited by 242
Häussinger, D., Dhiman, R. K., Felipo, V., Görg, B., Jalan, R., KIRCHEIS, G., Merli, M., Montagnese, S., Romero‐Gómez, M., Schnitzler, A., et al. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00366-6 · Cited by 231
Self-citationProbiotics Prevent Hepatic Encephalopathy in Patients with Cirrhosis: A Randomized Controlled Trial
Lunia, M. K., Sharma, B. C., Sharma, P., Sachdeva, S., & Srivastava, S. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.11.006 · Cited by 218
Teltschik, Z., Wiest, R., Beisner, J., Nuding, S., Hofmann, C., Schöelmerich, J., Bevins, C. L., Stange, E. F., & Wehkamp, J. (2011) · Hepatology · doi:10.1002/hep.24789 · Cited by 196
Dam, G., Vilstrup, H., Watson, H., & Jepsen, P. (2016) · Hepatology · doi:10.1002/hep.28737 · Cited by 190
Gut Microbiota: Its Role in Hepatic Encephalopathy
Rai, R., Saraswat, V. A., & Dhiman, R. K. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.12.003 · Cited by 180
Self-citationTsai, C.-F., Chen, M., Wang, Y., Chu, C., Huang, Y., Lin, H., Hou, M., Lee, F., Su, T., & Lu, C. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.09.007 · Cited by 175
Ferenci, P. (2017) · Gastroenterology report · doi:10.1093/gastro/gox013 · Cited by 161
Restless legs syndrome – Theoretical roles of inflammatory and immune mechanisms
Weinstock, L. B., Walters, A. S., & Paueksakon, P. (2012) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2011.09.003 · Cited by 158
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Fukui, H. (2019) · Diseases · doi:10.3390/diseases7040058 · Cited by 159
Li, G., Yang, M. J., Zhou, K., Zhang, L., Tian, L., Lv, S., Jin, Y. T., Qian, W., Xiong, H., Lin, R., et al. (2015) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1412.12047 · Cited by 146
The gut microbiota and the liver. Pathophysiological and clinical implications
Quigley, E. M. M., Stanton, C., & Murphy, E. F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.023 · Cited by 133
Maharshi, S., Sharma, B. C., Sachdeva, S., Srivastava, S., & Sharma, P. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.09.028 · Cited by 132
Gastrointestinal dysfunction in liver cirrhosis
Kalaitzakis, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14686 · Cited by 127
Diagnosis and Management of Small Intestinal Bacterial Overgrowth
Bohm, M. E., Siwiec, R. M., & Wo, J. M. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533613485882 · Cited by 123
Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update
Fukui, H. (2020) · Gut and Liver · doi:10.5009/gnl20032 · Cited by 121
Nardelli, S., Gioia, S., Ridola, L., Farcomeni, A., Merli, M., & Riggio, O. (2019) · Hepatology · doi:10.1002/hep.30304 · Cited by 109
Gut microbiota and liver disease
Goel, A., Gupta, M. C., & Aggarwal, R. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12556 · Cited by 112
Yan, A. W. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i4.110 · Cited by 112
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
Hartmann, P., Chen, W., & Schnabl, B. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00402 · Cited by 110
Sharma, A., Roy, A., Premkumar, M., Verma, N., Duseja, A. K., Taneja, S., Grover, S., Chopra, M., & Dhiman, R. K. (2022) · Hepatology International · doi:10.1007/s12072-022-10312-z · Cited by 110
Self-citationThe Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease
Ferolla, S. M., Armiliato, G. N. D. A., Couto, C. A., & Ferrari, T. C. A. (2014) · Nutrients · doi:10.3390/nu6125583 · Cited by 104
Presentation and complications associated with cirrhosis of the liver
Poordad, F. F. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1021905 · Cited by 102
Johnson, D. A., & Oldfield, E. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.031 · Cited by 101
Shahini, E., Sinagra, E., Vitello, A., Ranaldo, R., Contaldo, A., Facciorusso, A., & Maida, M. F. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i11.1685 · Cited by 97
Epidemiology of small intestinal bacterial overgrowth
Efremova, I., Maslennikov, R. V., Poluektova, E. A., Vasilieva, E., Zharikov, Y. O., Suslov, A. V., Letyagina, Y., Kozlov, E. M., Levshina, A., & Ivashkin, V. T. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i22.3400 · Cited by 112
Merli, M., Lucidi, C., Gregorio, V. D., Giannelli, V., Giusto, M., Ceccarelli, G., Riggio, O., & Venditti, M. (2014) · Liver International · doi:10.1111/liv.12593 · Cited by 95
Increased risk of cognitive impairment in cirrhotic patients with bacterial infections
Merli, M., Lucidi, C., Pentassuglio, I., Giannelli, V., Giusto, M., Gregorio, V. D., Pasquale, C., Nardelli, S., Lattanzi, B., Venditti, M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.012 · Cited by 98
Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy
Mancini, A., Campagna, F., Amodio, P., & Tuohy, K. M. (2018) · Food & Function · doi:10.1039/c7fo01528c · Cited by 89
Minimal Hepatic Encephalopathy Impairs Quality of Life
Agrawal, S., Umapathy, S., & Dhiman, R. K. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.11.006 · Cited by 90
Self-citationHydrogen Breath Tests in Gastrointestinal Diseases
Rana, S. V., & Malik, A. (2014) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0426-4 · Cited by 89
Self-citationLevitt, D., & Levitt, M. (2018) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s160921 · Cited by 75
Bluemel, S., Williams, B., Knight, R. D., & Schnabl, B. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00245.2016 · Cited by 85
Liver cirrhosis and immune dysfunction
Hasa, E., Hartmann, P., & Schnabl, B. (2022) · International Immunology · doi:10.1093/intimm/dxac030 · Cited by 90
Kwak, D. S., Jun, D. W., Seo, J. G., Chung, W., Park, S.-E., Lee, K. N., Saeed, W. K., Lee, H. L., Lee, O. Y., Yoon, B. C., et al. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000214 · Cited by 80
Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis
Maslennikov, R. V., Pavlov, C. S., & Ivashkin, V. T. (2018) · Hepatology International · doi:10.1007/s12072-018-9898-2 · Cited by 74
Shah, A., Shanahan, E. R., Macdonald, G. A., Fletcher, L. M., Ghasemi, P., Morrison, M., Jones, M., & Holtmann, G. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1608832 · Cited by 77
Current concepts in the pathophysiology and management of hepatic encephalopathy.
Frederick, R. T. (2011) · Europe PMC (PubMed Central) · Cited by 72
Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis
Ghosh, G., & Jesudian, A. B. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.08.006 · Cited by 71
The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders
Losurdo, G., D’Abramo, F. S., Indellicati, G., Lillo, C., Ierardi, E., & Leo, A. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103531 · Cited by 71
Fecal Calprotectin Use in Inflammatory Bowel Disease and Beyond: A Mini-Review
Alibrahim, B. K., AlJasser, M. I., & Salh, B. S. (2015) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2015/950286 · Cited by 71
The Link between Gut Microbiota and Hepatic Encephalopathy
Won, S., Oh, K., Gupta, H., Ganesan, R., Sharma, S. P., Jeong, J., Yoon, S. J., Jeong, M. K., Min, B. H., Hyun, J. Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168999 · Cited by 69
Gut Microbiota and Host Reaction in Liver Diseases
Fukui, H. (2015) · Microorganisms · doi:10.3390/microorganisms3040759 · Cited by 64
Pathogenesis, Diagnosis, and Treatment of Hepatic Encephalopathy
Atluri, D. K., Prakash, R., & Mullen, K. D. (2011) · Journal of Clinical and Experimental Hepatology · doi:10.1016/s0973-6883(11)60126-6 · Cited by 64
Gundling, F., Schmidtler, F., Hapfelmeier, A., Schulte, B., Schmidt, T., Pehl, C., Schepp, W., & Seidl, H. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02577.x · Cited by 61
Gudan, A., Jamioł-Milc, D., Hawryłkowicz, V., Skonieczna‐Żydecka, K., & Stachowska, E. (2022) · Nutrients · doi:10.3390/nu14245261 · Cited by 60
Miazga, A., Osiński, M., Cichy, W., & Żaba, R. W. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2014.09.001 · Cited by 61
Lata, J. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i24.2890 · Cited by 58
Gut microbiota and hepatic encephalopathy
Dhiman, R. K. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9388-0 · Cited by 58
Self-citationPathogenesis of Hepatic Encephalopathy
Ciećko-Michalska, I., Szczepanek, M., Słowik, A., & Mach, T. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/642108 · Cited by 58
Targeting Dysbiosis for the Treatment of Liver Disease
Anand, G. S., Zarrinpar, A., & Loomba, R. S. (2016) · Seminars in Liver Disease · doi:10.1055/s-0035-1571276 · Cited by 59
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
Nishimura, N., Kaji, K., Kitagawa, K., Sawada, Y., Furukawa, M., Ozutsumi, T., Fujinaga, Y., Tsuji, Y., Takaya, H., Kawaratani, H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136921 · Cited by 58
Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota
Garcovich, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i46.6693 · Cited by 56
Sroka, N., Rydzewska–Rosołowska, A., Kakareko, K., Rosołowski, M., Głowińska, I., & Hryszko, T. (2022) · Nutrients · doi:10.3390/nu15010090 · Cited by 63
Advances in the Evaluation and Management of Minimal Hepatic Encephalopathy
Montgomery, J. Y., & Bajaj, J. S. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0150-z · Cited by 53
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis
Campion, D., Giovo, I., Ponzo, P., Saracco, G. M., Balzola, F. A., & Alessandria, C. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i6.489 · Cited by 57
Motility Abnormalities in Irritable Bowel Syndrome
Dupont, A. W., Jiang, Z., Harold, S. A., Snyder, N., Galler, G. W., Garcia-Torres, F., & DuPont, H. L. (2014) · Digestion · doi:10.1159/000356314 · Cited by 52
Diagnosis and treatment of small intestinal bacterial overgrowth
Ponziani, F. R., Gerardi, V., & Gasbarrini, A. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1110017 · Cited by 52
Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step
Fukui, H. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00008 · Cited by 55
Hassouneh, R., & Bajaj, J. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020330 · Cited by 53
Beran, A., Aboursheid, T., Ali, A. H., Albunni, H. N., Mohamed, M. F. H., Vargas, A., Hadaki, N., Alsakarneh, S., Rex, D. K., & Guardiola, J. J. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003073 · Cited by 54
Rifaximin in the treatment of hepatic encephalopathy
Iadevaia, M. D., Iadevaia, M. D., Cesaro, Prete, D., Gaeta, & Zulli, C. (2011) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s11988 · Cited by 49
Luo, M., Xin, R., Hu, F.-R., Li, Y., Hu, S., & Bai, F. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i1.144 · Cited by 51
Rifaximin therapy and hepatic encephalopathy: Pros and cons
Zullo, A. (2012) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v3.i4.62 · Cited by 47
Nutritional assessment in cirrhotic patients with hepatic encephalopathy
Romeiro, F. G. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i30.2940 · Cited by 47
Xu, J., Ma, R., Chen, L.-F., Zhao, L., Chen, K., & Zhang, R. (2014) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(14)60280-0 · Cited by 44
Biologic properties and clinical uses of rifaximin
DuPont, H. L. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.546347 · Cited by 43
Jung, J. H., Kim, S. E., Suk, K. T., & Kim, D. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.913842 · Cited by 42
Probiotics in management of hepatic encephalopathy
Sharma, B. C., & Singh, J. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9826-x · Cited by 40
Etiological Spectrum of Cirrhosis in India: A Systematic Review and Meta-analysis
Swaroop, S., Vaishnav, M., Arora, U., Biswas, S., Aggarwal, A., Sarkar, S., Khanna, P., Elhence, A., Kumar, R. K., Goel, A., et al. (2023) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2023.10.002 · Cited by 36
Revaiah, P. C., Kochhar, R. K., Rana, S. V., Berry, N., Ashat, M., Dhaka, N., Reddy, Y. R., & Sinha, S. K. (2018) · JGH Open · doi:10.1002/jgh3.12045 · Cited by 36
Self-citationEffects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis.
Zhang, Y., Feng, Y., Cao, B., & Tian, Q. (2015) · PubMed Central · Cited by 35
Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
Liu, Y., Jin, Y., Li, J., Zhao, L., Li, Z., Xu, J., Zhao, F., Feng, J., Chen, H., Fang, C., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00470 · Cited by 35
Ma, Y.-J., Cao, Z., Li, Y., & Feng, S. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i21.2675 · Cited by 33
Romeiro, F. G., Yamashiro, F. D. S., Américo, M. F., Corá, L. A., Silva, G. F., Miranda, J. R. D. A., & Caramori, C. A. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-13 · Cited by 31
Nutrition status and small intestinal bacterial overgrowth in patients with virus-related cirrhosis.
Yao, J., Chang, L., Yuan, L., & Duan, Z. (2016) · PubMed · doi:10.6133/apjcn.2016.25.2.06 · Cited by 31
Jacobs, J. P., Dong, T. S., Agopian, V. G., Lagishetty, V., Sundaram, V., Noureddin, M., Ayoub, W. S., Durazo, F. A., Benhammou, J. N., Enayati, P. J., et al. (2018) · Hepatology Research · doi:10.1111/hepr.13207 · Cited by 31
Манжалій, Е., Moyseyenko, V. O., Кondratiuk, V. Y., Molochek, N., Falalyeyeva, T. M., & Kobyliak, N. M. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i3.634 · Cited by 31
Gut Microbiota, Inflammation and Hepatic Encephalopathy: A Puzzle with a Solution in Sight
Dhiman, R. K. (2012) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2012.08.004 · Cited by 31
Self-citationRisk factors for inadequate bowel preparation before colonoscopy: A meta‐analysis
Feng, L. L., Guan, J., Dong, R., Zhao, K., Zhang, M., Xia, S., Zhang, Y., Chen, L., Xiao, F., & Liao, J. (2024) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12607 · Cited by 31
Gastrointestinal Motility Disorders and Their Clinical Implications in Cirrhosis
Theocharidou, E., Dhar, A., & Patch, D. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/8270310 · Cited by 29
Tantai, X., Yang, L., Wei, Z., Xiao, C., Chen, L., Wang, J., & Liu, N. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i21.2683 · Cited by 29
Hansen, M. K. G., Kjærgaard, K., Eriksen, L. L., Grønkjær, L. L., Mikkelsen, A. C. D., Sandahl, T. D., Vilstrup, H., Thomsen, K. L., & Lauridsen, M. M. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00913-w · Cited by 29
Zhu, J., Qi, X., Yu, H., Yoshida, E. M., Mendez-Sanchez, N., Zhang, X., Wang, R., Deng, H., Li, J., Han, D., et al. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640618773564 · Cited by 28
Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis
Morán, S., López-Sánchez, M., Milke-García, M. D. P., & Rodríguez-Leal, G. A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i22.3050 · Cited by 28
Gut microbiome and liver diseases
Tilg, H., & Moschen, A. R. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch30 · Cited by 29
Metadata
- Authors
- Gupta, A., Dhiman, R. K., Kumari, S., Rana, S., Agarwal, R., Duseja, A., & Chawla, Y.
- Affiliations
- Post Graduate Institute of Medical Education and Research (IN)
- Corresponding author
- Dhiman, Radha K
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 53
- Issue
- 5
- Pages
- 849-855
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1989507260
- Cited by
- 202
- References
- 50
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 11 · 2023: 19 · 2022: 14 · 2021: 5 · 2020: 9 · 2019: 17 · 2018: 13 · 2017: 12 · 2016: 16 · 2015: 18 · 2014: 22 · 2013: 8 · 2012: 18
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- minimal hepatic encephalopathy, small intestinal bacterial overgrowth, liver cirrhosis, glucose breath test, lactulose breath test, Child-Pugh score, gastrointestinal motility disorders, rifaximin, probiotics, prokinetic agents
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Bacteria, Cross-Sectional Studies, Female, Gastrointestinal Transit, Hepatic Encephalopathy, Humans, Intestine, Small, Liver Cirrhosis, Male, Middle Aged, Prevalence, Multivariate Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review